Cidara's Once-Weekly Antifungal Gets Phase III Boost From Mundipharma

 
• By John Davis
  
Mold
Aspergillus can cause fungal infections in patients • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anti-infective

More from Therapeutic Category